Delivery Order SPE2DR25D1053-SPE2DR26FV484
Award Date 1/13/26
Potential Completion Date 1/14/26
Potential Value $9.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $9,380.88 to AmerSourceBergen Drug Corp on January 12, 2026, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. The contract will be performed at the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. AmerSourceBergen Drug Corp, a subsidiary of parent company...
- The Defense Logistics Agency awarded a delivery order valued at $28.6K to Amerisourcebergen Drug Corp for the supply of Vemlidy 25mg tablets (30-count) with a firm fixed-price structure. The award, issued on January 14, 2026, is scheduled for completion by February 11, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This competitive, non-set-aside contract represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,873.72 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-unit package) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contract...
- The Defense Logistics Agency awarded a delivery order valued at $7,602.53 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on January 14, 2026, with an ultimate completion date of January 15, 2026. This non-set-aside, firm fixed-price contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $46,670.65 to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract is scheduled for completion by January 15, 2026, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,725.36 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (quantity: 30-unit bottles). This competitively awarded, firm fixed price contract is scheduled for completion by November 28, 2025, and represents a non-set-aside procurement. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion...
- The Defense Logistics Agency awarded a delivery order valued at $4,700.52 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $8,586.21 firm fixed price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's Corporate...
- The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp (subsidiary of Cencora, Inc.) on January 14, 2026, for the supply of Vemlidy 25 mg tablets in quantities of 30 tablets, with a ceiling value of $1,802.78 and an ultimate completion date of January 15, 2026. The contract utilizes a firm fixed-price structure with no small business set-aside designation. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,139.66 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under...